Chimeric antigen receptor-modified T cell therapy in chronic lymphocytic leukemia

Chronic lymphocytic leukemia (CLL), a common type of B cell chronic lymphoproliferative disorder in adults, has witnessed enormous development in its treatment in recent years. New drugs such as ibrutinib, idelalisib, and venetoclax have achieved great success in treating relapsed and refractory (R/...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Yixin, Xu, Wei, Li, Jianyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247712/
https://www.ncbi.nlm.nih.gov/pubmed/30458878
http://dx.doi.org/10.1186/s13045-018-0676-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247712/
https://www.ncbi.nlm.nih.gov/pubmed/30458878
http://dx.doi.org/10.1186/s13045-018-0676-3

Ejemplares similares